Asia Pacific Eye Health Supplement Market Forecast to 2027: Analysis by Ingredient type; Indication, Cataract, Dry Eye syndrome, Others; and Form, and Countries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Eye Health Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Ingredient type; Indication, Cataract, Dry Eye syndrome, Others; and Form, and Countries" report has been added to ResearchAndMarkets.com's offering.

Asia Pacific Eye Health Supplement Market is expected to reach US$ 593.12 million by 2027 from US$ 370.69 million in 2019; it is estimated to grow at a CAGR of 6.2% from 2020 to 2027.

The Asia Pacific Eye Health Supplement market based on ingredient type is segmented into Lutein and Zeaxanthin, Antioxidants, Omega-3 fatty acids, Coenzyme Q10, Flavonoids, Astaxanthin, Alpha-Lipoic acid, Others. In 2019, the Lutein and Zeaxanthin segment accounted for the largest share of the Asia Pacific Eye Health Supplement market.

The growth of the market for this segment is attributed to their effectiveness in reducing the risk of chronic eye diseases and ability to filter harmful blue wavelengths of light which helps in maintaining healthy cell in eye. However, the flavonoids segment is likely to register the highest CAGR in the market during the forecast period.

The growth of the Asia Pacific Eye Health Supplement market is mainly attributed to increasing prevalence of eye related disorders and growing aging population. However, high costs of eye health supplement products and limited availability of these supplements in emerging markets is the major factor hindering the market growth in Asia Pacific.

A few of the leading companies operating in the Asia Pacific Eye Health Supplement market are Nordic Naturals, Herbalife Nutrition Ltd., The Nature's Bounty Co, AMWAY, Pfizer Inc., Alcon Inc., Bausch Health Companies Inc., Vitabiotics Ltd., Alliance Pharma PLC, Allergan Plc. and others.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

2. Asia Pacific Eye Health Supplement Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Eye Health Supplement Market - Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Eye Health Supplement Market - Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Eye Health Supplement Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Growing Prevalence of Eye Diseases

5.1.2 Aging Population

5.2 Key Market Restraints

5.2.1 High Cost of Supplements and Lack of Product Availability in Market

5.3 Key Market Opportunities

5.3.1 Increasing Number of Industrial Developments

5.4 Future Trends

5.4.1 Changes in Lifestyle

5.5 Impact Analysis of Drivers and Restraints

6. Eye Health Supplement Market - Asia Pacific Analysis

6.1 Asia Pacific Eye Health Supplement Market Revenue Forecast and Analysis

6.2 Asia Pacific Eye Health Supplement Market, by Countries - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Asia Pacific Eye Health Supplement Market Analysis - by Indication

7.1 Overview

7.2 Asia Pacific Eye Health Supplement Market Revenue Share, by Indication (2019 and 2027)

7.3 Age-related Macular Degeneration (AMD)

7.4 Cataract

7.5 Dry Eye Syndrome

8. Asia Pacific Eye Health Supplement Market Analysis - by Ingredient Type

8.1 Overview

8.2 Eye Health Supplement Market Revenue Share, by Product (2019 and 2027)

8.3 Lutein and Zeaxanthin

8.4 Antioxidants

8.5 Omega-3 Fatty Acids

8.6 Coenzyme Q10

8.7 Flavonoids

8.8 Astaxanthin

8.9 AlphaLipoic Acid

9. Asia Pacific Eye Health Supplement Market Analysis - by Form

9.1 Overview

9.2 Asia Pacific Eye Health Supplement Market Share, by Forms, 2019 and 2027, (%)

9.3 Tablet

9.4 Capsule

9.5 Drops

10. Asia Pacific Eye Health Supplement Market Analysis and Forecasts to 2027 - Regional Analysis

11. Impact of COVID-19 Pandemic on Asia Pacific Eye Health Supplement Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

• Nordic Naturals
• Herbalife Nutrition Ltd.
• The Nature's Bounty Co
• AMWAY
• Pfizer Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Vitabiotics Ltd.
• Alliance Pharma PLC
• Allergan Plc.

For more information about this report visit https://www.researchandmarkets.com/r/db7kt8